PPD downgraded by Credit Suisse with a new price target
$PPD
Biotechnology: Commercial Physical & Biological Resarch
Health Care
Credit Suisse downgraded PPD from Outperform to Neutral and set a new price target of $47.50 from $42.00 previously
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 8/5/2021 | $47.50 | Neutral | Credit Suisse |